Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
about
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinoloneMutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolonesThe new fluoroquinolones: A critical reviewPharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelDNA cleavage activities of Staphylococcus aureus gyrase and topoisomerase IV stimulated by quinolones and 2-pyridones.Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.Cloning, sequencing, and expression of the DNA gyrase genes from Staphylococcus aureus.Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.New quinolones and gram-positive bacteria.In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.Bacterial resistance to fluoroquinolones: lessons to be learned.Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus.Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity.Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
P2860
Q24629223-F63DAB97-D5B1-431A-A2B0-E823AA74ACFFQ33690598-B9866D87-1FC6-4794-8CE9-233C6C54AD2BQ33976061-644137FD-E134-4CF7-B975-8B2CCD6CA622Q34729788-E592F8C0-6B29-4EB5-8058-F63E038D7BEBQ35111853-D4A723C5-0F5C-487F-85FC-298AA209C493Q35649595-2C1FE4AE-0BA4-418B-A808-2BAFFC71F033Q35822889-894623F8-F0F8-490A-B356-516A0BCB5F48Q39471127-DC61C45E-2D1E-49E3-91C6-E73E7B24DBC7Q39780025-B81BF623-CA91-4C73-A0C0-6474D4B7DA43Q39783230-D0B11A9E-0B40-41FE-9497-F33A9F9101DDQ39928815-D88F873D-E56A-461D-877C-0EAE1A7F6CE4Q40088541-712BE372-F9EA-4049-B464-7D8306AB31ADQ40284884-9928841B-17F6-4C1A-8AE0-DC1480AF8404Q40285332-D0BE7A89-C028-4878-A576-7D17BCB06391Q40286293-1852B5CC-C8EA-427A-BBF5-66F84BA0F3B6Q40633563-B1693EAF-EC42-413B-A63F-3EFAD5D13AD9Q42132631-5DF4E781-75B8-46BA-AB13-ABFB4C7DAE19Q54103069-26902502-BE29-4328-A6EA-DE149DB112FDQ54153790-0A41BA5C-BEF9-47A7-BBB1-3E85D5909928
P2860
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
@en
type
label
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
@en
prefLabel
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
@en
P2093
P2860
P356
P1476
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.12.2562
P407
P577
1991-12-01T00:00:00Z